Blood glucose, food intake, and major tissues including brown adipose, liver, and spleen weights were similar between RETA and SEMA, yet RETA uniquely reduced adiposity and delayed tumor latency suggesting that targeting a single receptor GLP1R was effective for many physiologic and metabolic benefits, but the additional agonism of GIPR and GPCR by RETA uniquely impacted adiposity, tumor onset, and tumor progression
Administration of gemcitabine in nude mice bearing subcutaneous PC cell line tumors leads to increased growth of Proteobacteria and Akkermansia muciniphila, which potentiate inflammation and/or mucin degradation
Study Limitations The analysis did not capture prescribing indication, relied on self-reported diabetes status, did not identify tirzepatide separately in 2022, and reported nominal payments without adjusting for inflation
In the last two years, hundreds of businesses have cropped up to meet the surge in demand for the obesity and diabetes medications known as GLP-1s